EUCTR2017-003473-34-NL进行中（未招募）1 期
Effect and safety of semaglutide 2.4 mg once-weekly in subjects with overweight or obesity who have reached target dose during run-in period
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 900
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Male or female, age = 18 years at the time of signing informed consent
- •2. BMI = 30 kg/sqm or = 27 kg/sqm with the presence of at least one of the following weightrelated comorbidities (treated or untreated): hypertension, dyslipidaemia, obstructive sleep apnoea or cardiovascular disease
- •3. History of at least one self-reported unsuccessful dietary effort to lose body weight
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 720
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 180
排除标准
- •1. HbA1c = 48 mmol/mol (6.5%) as measured by central laboratory at screening
- •2. A self-reported change in body weight > 5 kg (11 lbs) within 90 days before screening
- •irrespective of medical records
研究者
相似试验
进行中（未招募）
1 期
Research study investigating how well semaglutide works in people with type 2 diabetes suffering from overweight or obesity1. Obesity2. Diabetes Mellitus, Type 2MedDRA version: 20.0Level: PTClassification code 10029883Term: ObesitySystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 20.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2017-003414-10-ESovo Nordisk A/S1,200
进行中（未招募）
1 期
Research study investigating how well semaglutide works in people suffering from overweight or obesityObesityEUCTR2017-003436-36-GBovo Nordisk A/S1,950
进行中（未招募）
3 期
STEP-1: Research study investigating how well semaglutide works in people suffering from overweight or obesityCTRI/2018/07/014765ovo Nordisk AS
进行中（未招募）
1 期
Research study investigating how well semaglutide works in people suffering from overweight or obesityMedDRA version: 20.0Level: PTClassification code 10029883Term: ObesitySystem Organ Class: 10027433 - Metabolism and nutrition disordersObesityEUCTR2017-003436-36-DKovo Nordisk A/S1,950
进行中（未招募）
1 期
Research study investigating how well semaglutide works in people suffering from overweight or obesityMedDRA version: 20.0Level: PTClassification code 10029883Term: ObesitySystem Organ Class: 10027433 - Metabolism and nutrition disordersObesityEUCTR2017-003473-34-DKovo Nordisk A/S900